Quality Control (QC)

Contact: Allison Torgesen
Location: DE-330
Contact phone: (206) 667-7789
Contact e-mail: atorgesen@fredhutch.org

QC supports two GMP manufacturing facilities (BPF and CPF) of novel biological molecules and innovative cell-based therapies which is required by the FDA for first-in-human Phase I/II clinical research studies.

Capabilities include:

  • Bioburden/microbial enumeration
  • Endotoxin
  • Sterility
  • Mycoplasma
  • Flow Cytometry
  • Cell-based potency (IFNg, Cr-51)
  • Residual Bead enumeration
  • IEF gel
  • Residual Protein A ELISA
  • Residual HCP ELISA
  • Protein Concentration by UV/vis
  • pH
  • Osmolality
  • HPLC

Doing Business with Therapeutic Products Program (TPP)

(206) 667-6753